COMPUMED SLATED TO PARTICIPATE AT CHINAMED EXPO
DICOM OsteoGramŽ to be Formally Introduced to Chinese Market

LOS ANGELES, April 20, 2004 -- CompuMed, Inc. (CMPD.OB) -- a medical informatics company serving the healthcare community with diagnostic software solutions -- today announced that the company will participate at the ChinaMed International Medical Instruments and Equipment Exhibition in Beijing (April 26-29). During the Expo, CompuMed will team up with its licensee and distribution partners to debut its new DICOM OsteoGram system to the Chinese market.

Now in its 16th year, ChinaMed has become the largest and most influential medical instrument and equipment show in China. The previous ChinaMed exhibition was attended by more than 40,000 professionals. According to surveys, 21 percent of the attendees were there specifically to see diagnostic imaging equipment. The exhibition is sponsored primarily by major medical purchasing organizations in Mainland China, including the nation's military.

"We are delighted to team up with our partners from Orex Computed Radiography and their local distribution arm- Siemens LTD China, to introduce the DICOM OsteoGram at ChinaMed," said CompuMed CEO, Jerry McLaughlin. "In addition, we plan to make a formal presentation at a satellite meeting sponsored by Golden Xi Tong, CompuMed's distributor for film-based OsteoGram products in China."

According to ChinaMed statistics, the value of medical imports from January to October of 2003 reached $2.1 billion, up 41 percent over the previous year. Chinese hospitals currently import 100 percent of their top- grade imaging equipment. The future looks especially promising for filmless x-ray platforms and PACS networks, as China moves rapidly into the digital imaging age.

The OsteoGram is a software-based imaging system that enables healthcare providers to screen, diagnose and monitor osteoporosis using a conventional film-based hand x-ray or a digital image derived from filmless x-ray equipment. CompuMed recently introduced a DICOM (Digital Communications and Imaging in Medicine) compliant version for use on digital imaging platforms. DICOM is the information standard that allows the new generation of medical imaging equipment to interconnect. DICOM-based systems have become a high growth segment of the medical imaging market.

About CompuMed:

Founded in 1973, CompuMed, Inc. (OTC Bulletin Board: CMPD) is a leading provider of computer-aided telemedicine and diagnostics technology. The company's core products are the OsteoGramŽ and CardioGram systems. The OsteoGram, which is cleared by the FDA for commercial use, is an accurate and precise technology for low-cost osteoporosis testing. The CardioGram system remotely interprets electrocardiograms and is used by private practice, government and corporate healthcare providers nationwide. The CardioGram also has the capability to automatically provide an over-read (i.e., follow-up review) by a cardiologist. CompuMed is in Los Angeles. Visit CompuMed at www.compumed.net or call (310) 258-5000.

About Dutchess Advisors, LLC:

Dutchess Advisors, LLC is engaged in assisting growth companies in all facets of their long-term strategy by providing capital and progressive business solutions. Through Dutchess Private Equities Fund, LP, it manages a portfolio of private investments in public equities. Although the Company's investments are passive in nature, Dutchess provides a wide range of advisory services to assist its client companies long after the initial infusion of capital. Founded in 1996, Dutchess has been involved in excess of $200 million in financings for such companies.

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks defined in this document. All such forward-looking statements whether written or oral, and whether made by or on behalf of the Company are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof except as required by law.

CONTACT: Erik Deutsch - Tellem Worldwide, +1 (310) 479-6111 x.15, edeutsch@tellem.com